Taking Fuel From the IBD Fire: Applying New Evidence on Sphingosine-1-Phosphate Receptor Modulation as an Effective Oral Option for Management of Ulcerative Colitis
•Transferir como PPT, PDF•
0 gostou•18 visualizações
Chair, Miguel Regueiro, MD, and Anita Afzali, MD, MPH, MHCM, FACG, AGAF, discuss inflammatory bowel disease in this CME/MOC activity titled “Taking Fuel From the IBD Fire: Applying New Evidence on Sphingosine-1-Phosphate Receptor Modulation as an Effective Oral Option for Management of Ulcerative Colitis.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3B7FdmG. CME/MOC credit will be available until June 8, 2024.
